RECRUITING

Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay

Description

This is a national-level research study of neurologists and dementia specialists. The purpose of this study is to assess the clinical evaluation and management recommendations made by practicing providers for patient simulations with symptoms of cognitive decline.

Conditions

Alzheimer Disease (AD)Cognitive Decline
Talk to us

Related Conditions:

Alzheimer Disease (AD)Cognitive Decline

Study Overview

On this page

Study Details

Study overview

This is a national-level research study of neurologists and dementia specialists. The purpose of this study is to assess the clinical evaluation and management recommendations made by practicing providers for patient simulations with symptoms of cognitive decline.

Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay: A QURE Virtual Patient Randomized Controlled Trial

Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay

Condition
Alzheimer Disease (AD)
Intervention / Treatment

-

Contacts and Locations

Saint Louis

QURE Healthcare, Saint Louis, Missouri, United States, 63110

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Board-certified in neurology for at least two years (and no more than 35 years
  • * Average at least 20 hours per week of clinical and patient care duties over the past six months
  • * Routinely evaluate patients at risk for Alzheimer's disease
  • * Practicing in the United States
  • * Able to read English
  • * Access to the internet
  • * Not participating in a clinical research study of the AD assay
  • * Informed, signed, and voluntarily consented to participate in this study
  • * Board-certified in neurology for less than two years
  • * Board certification in neurology over 35 years ago
  • * Unable to read English
  • * Unable to access the internet
  • * Not practicing in the United States
  • * Not averaging at least 20 hours per week of clinical or patient care duties over the past six months
  • * Participating in a clinical research study of the AD assay
  • * Do not voluntarily consent to participate in this study

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Qure Healthcare, LLC,

Trever Burgon, PhD, PRINCIPAL_INVESTIGATOR, QURE Healthcare

Study Record Dates

2025-12-31